公司資料
Trevena 股價、新聞與催化劑
- 股票代碼:
- TRVN
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
0.00 USD (0.00%)
收盤價
最後更新: 2026年8月17日
—
市值
股價為何變動
Current closing-price context is not available for TRVN.
公司概覽
業務概覽
Trevena was a specialty neuroscience and pain company focused on opioid-sparing and CNS therapeutics. Its story centered on difficult pain and neurologic indications where commercial uptake depends on both clinical differentiation and regulatory execution.
所在地與產業分類
Trevena was headquartered in the United States and listed on NASDAQ, placing it in the small-cap biopharmaceutical category. It sat in the high-risk neuroscience and pain niche rather than broad healthcare.
商業模式特徵
The business model was driven by late-stage development, product commercialization attempts, and the ability to secure reimbursement and physician adoption. Investors watched clinical data, product launches, and the company's capital structure closely.
生技產業定位
Trevena occupied a catalyst-sensitive small-cap CNS niche. It is best viewed as a legacy specialty-pharma story where execution risk and funding pressure were always central to the stock.
未來催化劑
- Trevena is now mostly a legacy / closeout story, so the catalysts are any remaining asset or strategic update rather than a fresh development milestone. The market no longer treats it as a live growth name.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。